MICROPORT NEUROTECH LIMITED Financials MicroPort NeuroTech Limited
Equities
2172
KYG6083E1098
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.92 HKD | -0.78% |
|
-1.41% | -25.98% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 11,810 | 6,482 | 4,858 | - | - |
| Enterprise Value (EV) 1 | 10,982 | 6,482 | 4,858 | 4,858 | 4,858 |
| P/E ratio | -507 x | 44.5 x | 20.8 x | 15.7 x | 11.6 x |
| Yield | - | - | 0.72% | 0.78% | - |
| Capitalization / Revenue | 21.6 x | 9.74 x | 5.59 x | 3.99 x | 3.28 x |
| EV / Revenue | 21.6 x | 9.74 x | 5.59 x | 3.99 x | 3.28 x |
| EV / EBITDA | 65.8 x | 30.3 x | 17 x | 13.4 x | - |
| EV / FCF | 61.7 x | - | 20.8 x | 16.9 x | 14.2 x |
| FCF Yield | 1.62% | - | 4.82% | 5.91% | 7.04% |
| Price to Book | - | - | 2.72 x | 2.4 x | - |
| Nbr of stocks (in thousands) | 582,658 | 582,658 | 582,658 | - | - |
| Reference price 2 | 20.27 | 11.13 | 8.338 | 8.338 | 8.338 |
| Announcement Date | 3/29/23 | 3/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 547.4 | 665.6 | 868.5 | 1,219 | 1,480 |
| EBITDA 1 | - | 179.5 | 213.7 | 286 | 363 | - |
| EBIT 1 | - | 121.7 | 219.8 | 269 | 346 | 438.5 |
| Operating Margin | - | 22.24% | 33.02% | 30.97% | 28.38% | 29.64% |
| Earnings before Tax (EBT) 1 | - | - | 162.1 | 260.5 | 348 | 468 |
| Net income 1 | 24.17 | -21.76 | 145.5 | 232.5 | 309 | 418 |
| Net margin | - | -3.98% | 21.87% | 26.77% | 25.35% | 28.25% |
| EPS 2 | 0.0500 | -0.0400 | 0.2500 | 0.4000 | 0.5300 | 0.7200 |
| Free Cash Flow 1 | - | 191.5 | - | 234 | 287 | 342 |
| FCF margin | - | 34.99% | - | 26.94% | 23.54% | 23.12% |
| FCF Conversion (EBITDA) | - | 106.67% | - | 81.82% | 79.06% | - |
| FCF Conversion (Net income) | - | - | - | 100.65% | 92.88% | 81.82% |
| Dividend per Share 2 | - | - | - | 0.0600 | 0.0650 | - |
| Announcement Date | 6/28/22 | 3/29/23 | 3/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | 828 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 192 | - | 234 | 287 | 342 |
| ROE (net income / shareholders' equity) | - | -3.35% | - | 13.5% | 15.8% | 17.7% |
| ROA (Net income/ Total Assets) | - | -1.38% | - | 11.1% | 12.9% | 14.3% |
| Assets 1 | - | 1,579 | - | 2,104 | 2,395 | 2,923 |
| Book Value Per Share 2 | - | - | - | 3.070 | 3.470 | - |
| Cash Flow per Share 2 | - | - | - | 0.4500 | 0.5600 | - |
| Capex 1 | - | 32.3 | - | 34 | 35 | 36 |
| Capex / Sales | - | 5.9% | - | 3.91% | 2.87% | 2.43% |
| Announcement Date | 6/28/22 | 3/29/23 | 3/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.338
CNY
Average target price
12.94
CNY
Spread / Average Target
+55.14%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -25.98% | 671M | |
| +12.01% | 128B | |
| -5.89% | 11.26B | |
| +6.26% | 9.28B | |
| +35.53% | 5.42B | |
| +8.68% | 3.45B | |
| -8.89% | 2.8B | |
| -10.68% | 2.1B | |
| -10.77% | 1.98B | |
| -26.31% | 1.71B |
- Stock Market
- Equities
- 2172 Stock
- Financials MicroPort NeuroTech Limited
